XML 40 R97.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED FINANCIAL INFORMATION - PARENT COMPANY ONLY (Details 3) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 12 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash Flows from Operating Activities:                      
Net loss $ (5,058) $ (6,521) $ (967) $ (1,165) $ 436 $ (434) $ 189 $ (526) $ (13,711) $ (335) $ (31,720)
Adjustments to reconcile net loss to net cash provided (used) by operating activities:                      
Equity in trust                 (7) (4) (6)
Stock-based compensation                 46    
Increase in accrued interest payable                 2,126 1,538 (117)
Increase in other liabilities                 12 569 1,825
Net Cash (Used) Provided by Operating Activities                 (11,044) 3,294 5,792
Cash Flows from Investing Activities:                      
Net Cash Provided by Investing Activities                 89,860 170,151 150,856
Cash Flows from Financing Activities:                      
Increase in borrowed funds                 (12,187) 16,190 7,981
Proceeds from issuance of common stock, net of stock issuance costs                   29 528
Net Cash Used by Financing Activities                 (132,191) (79,304) (168,507)
Net (Decrease) Increase in Cash and Cash Equivalents                 (53,375) 94,141 (11,859)
Cash & Cash Equivalents at Beginning of Year       168,646       74,505 168,646 74,505 86,364
Cash & Cash Equivalents at End of Year 115,271       168,646       115,271 168,646 74,505
Parent company
                     
Cash Flows from Operating Activities:                      
Net loss                 (13,711) (335) (31,720)
Adjustments to reconcile net loss to net cash provided (used) by operating activities:                      
Equity in undistributed loss (income) of subsidiary                 11,206 (2,248) 29,076
Equity in trust                 (7) (4) (6)
Stock-based compensation                 46    
Increase in other assets                 (46)    
Increase in accrued interest payable                 2,512 2,486 628
Increase in other liabilities                 2    
Net Cash (Used) Provided by Operating Activities                 2 (101) (2,022)
Cash Flows from Investing Activities:                      
Investment in capital of subsidiary                   (3,000) (1,520)
Net Cash Provided by Investing Activities                   (3,000) (1,520)
Cash Flows from Financing Activities:                      
Increase in borrowed funds                     1,900
Proceeds from issuance of common stock, net of stock issuance costs                   29 528
Net Cash Used by Financing Activities                   29 2,428
Net (Decrease) Increase in Cash and Cash Equivalents                 2 (3,072) (1,114)
Cash & Cash Equivalents at Beginning of Year       353       3,425 353 3,425 4,539
Cash & Cash Equivalents at End of Year $ 355       $ 353       $ 355 $ 353 $ 3,425